Lage A

Idioma: Ingles.
Referencias bibliográficas: 9
Paginas: 8-12
Archivo PDF: 501.85 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Ernst & Young. Beyond Borders: The Global Biotechnology Report 2007 [monograph on the Internet].OECD; 2007 [cited 2008 Jun]. Available from: http://www.ey.com/Publication/vwLUAssets/beyond_borders2007/$FILE/ BeyondBorders2007.pdf

2. van Beuzekom B, Arundel A. OECD, 2006. Biotechnology Statistics [monograph on the Internet]. OECD; 2006 [cited 2008 Jun]. Available from: http:// www.oecd.org/dataoecd/51/59/36760212.pdf

3. Pharmaceutical Manufacturers Association of America, 2008. Biotechnology Medicines 2008 [monograph on the Internet]. PhRMA; 2008 [cited 2009 Apr]. Available from: http://www.phrma.org/images/110308%20biotech%20 2008.pdf

4. Eisenhauer EA. Response evaluation: beyond RECIST. Ann Oncol. 2007 Jul;18(Suppl 9):ix29-32. Review.

5. Evenson D. Cuba’s Biotechnology Revolution. MEDICC Review. 2007 Fall;9(1):8-10.

6. Lage A. Connecting science to population health: the “closed loop” approach. MEDICC Review. 2007 Fall;9(1):48.

7. Lage A, Pérez R, Fernández LE. Therapeutic Cancer Vaccines: at midway between immunology and pharmacology. Curr Cancer Drug Targets. 2005 Dec;5(8):611-27.

8. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC. Effectiveness of Chemotherapy for Advanced Lung Cancer in the Elderly: Instrumental Variable and Propensity Analysis. J Clin Oncol. 2001 Feb 15;19(4):1064-70.

9. Lage A. Connecting immunology research to public health: Cuban biotechnology. Nat Immunol. 2008 Feb;9(2):109-12.